Sydney, June 5 -- Australian researchers have achieved a major advance in tackling Staphylococcus aureus, commonly known as golden staph, a superbug that causes more than a million deaths worldwide each year.
The world-first initiative has demonstrated that real-time genome sequencing during severe infections allows doctors to quickly identify resistance mutations, personalize treatment, and help curb the spread of antibiotic resistance, according to a release from the Melbourne-based Peter Doherty Institute for Infection and Immunity (Doherty Institute) on Wednesday.
Collaborating with seven local hospitals, scientists from the Doherty Institute said that traditionally, hospital laboratories identify bacteria using standard tests that ...